Alison Rodriguez

Advanced radiotherapy treatment, combined with chemotherapy, in small cell lung cancer leads to higher survival rates and lower toxicity, according to a new study.

The FDA has approved expanding the use of the DigniCap Cooling System to prevent chemotherapy-associated alopecia for all patients with solid tumors.

While a connection has been found between psoriasis and cardiovascular disease, a recent study has found no link between another skin disease, atopic dermatitis, and cardiovascular disease.

Sarepta Therapeutics has announced a new collaboration with Genethon for gene therapy research in efforts to develop new Duchenne muscular dystrophy (DMD) treatments.

New clinical trial research presented at the European Society for Medical Oncology 19th World Congress on Gastrointestinal Cancer suggests that ARMO BioSciences’ immuno-oncology drug, AM0010, is effective in treating patients with advanced pancreatic cancer.

Those with chronic obstructive pulmonary disease (COPD) may be more likely to suffer from a heart attack or stroke following an acute exacerbation if they have a history or at risk of cardiovascular disease (CVD).

When medical care recommendations are followed for handling patients with opioid addiction, the death rate among these patients can decrease by up to one-third, according to new research.

With the Fourth of July quickly approaching, many people are planning to spend time outside under the sun. Sunscreen is necessary for this time of year to protect against the sun’s harmful rays; however, it is only effective if it is used properly.

Radiotherapy is responsible for a significant reduction in breast cancer mortality. However, the treatment may lead to the development of a different cancer or heart disease in the future.

A higher intake of fish may be associated with reduced disease activity in patients with rheumatoid arthritis (RA).

Several studies looked at older diabetes drugs for possible effects on breast cancer prevention, as well as the effects of diet and alcohol use on breast cancer risk.

While treatments prescribed for people with chronic pulmonary disease (COPD) and asthma—COPD overlap syndrome (ACOS) are similar, there is a need for a clearer therapeutic approach for patients with ACOS, according to a new study.

Data from multiple studies have demonstrated the efficacy of Venclexta/Venclyxto in treating relapsed or refractory chronic lymphocytic leukemia, according to Roche.

The US Multi-Society Task Force recently released new recommendations for colorectal cancer (CRC) screenings. Since there has been an increase in CRC among younger Americans, while incidences in those over age 50 is decreasing, the recommendations consider the importance of systematic screening tests even for people without any CRC symptoms.

The FDA has approved Genentech’s Rituxan Hycela for subcutaneous injection for the treatment of certain blood cancers. Rituxan Hycela has similar outcomes as Rituxan, but can be delivered in 5 to 7 minutes compared with 1.5 hours for Rituxan.

Statins may cause symptoms of onset Parkinson’s disease to advance more quickly in those who are susceptible to the disease, according to a new study published in Movement Disorders.

A phase 3 clinical trial of patients with relapsing multiple sclerosis and primary progressive multiple sclerosis found that Ocrevus (ocrelizumab) significantly reduced disease progression, according to results released by Genentech.

The FDA has approved the use of Janssen Biotech, Inc’s immunotherapy Darzalex in combination with pomalidomide and dexamethasone. Darzalex is used to treat multiple myeloma patients who have previously received at least 2 therapies with lenalidomide and a proteasome inhibitor.

Researchers investigating the risks of breast, ovarian, and contralateral breast cancer for mutation carriers found that family history and mutation position are important for determining cancer risk estimates, according to a study published in JAMA.

The update follows an earlier report from Express Scripts on the nation's crisis, which revealed that women are using more opioids than men.

The FDA has approved Baxdela, a drug intended to treat adults with acute bacterial skin and skin structure infections caused by susceptible bacteria. Baxdela is also effective in treating MRSA and against other gram-positive or gram-negative pathogens.

A new report from the United States Government Accountability Office is calling for pharmacy systems to better serve veterans through additional capabilities for viewing, exchanging, and using data.

States should maintain laws and policies to regulate cost-sharing in private health insurance because of the barrier it creates between the consumer and health services, reveals a recent report.

Patients with rheumatoid arthritis with high multi-biomarker disease activity scores have an increased risk of radiographic progression, according to a new analysis of 6 different studies.

New data has demonstrated an association between high Vectra DA scores and an increased risk of joint damage progression in patients with rheumatoid arthritis.

On June 14, 2017, The Institute for Clinical and Economic Review (ICER) added a “New Evidence Update” to the 2015 review of the comparative clinical effectiveness and value of PCSK9 inhibitors for management of high cholesterol.

On June 14, 2017, Western Connecticut Health Network (WCHN) announced its launch of a new study that will research the connection between pancreatic cancer and new-onset diabetes. This $2.7 million study will span 3 years and aims to discover a method to detect pancreatic cancer while it can still be cured.

Patients with chronic obstructive pulmonary disease (COPD) may dismiss medical advice if the benefit of the treatment is insignificant in comparison to the burden.

A drug previously used in an attempt to treat cancer, now has the potential to be repurposed to treat Duchenne muscular dystrophy.

The Supreme Court of the United States ruled in favor of Sandoz, on Monday, by allowing biosimilars to give notice of commercial marketing before or after FDA approval-meaning biosimilar products can be available sooner.